Clinical Trial Results:
            A Multicenter, Multinational Study of the Effects of Fabrazyme® (agalsidase beta) Treatment on Lactation and Infants
    
|     Summary | |
|     EudraCT number | 2006-001910-33 | 
|     Trial protocol | GB AT | 
|     Global completion date | |
|     Paediatric regulatory details | |
|     Is the trial part of an agreed EMA paediatric investigation plan? | |
|     Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | |
|     Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | |
|     Results information | |
|     Results version number | v2(current) | 
|     This version publication date | 
                                    12 Feb 2025
                             | 
|     First version publication date | 
                                    23 Feb 2023
                             | 
|     Other versions | v1 | 
|     Version creation reason | 
 | 
|     Summary report(s) | AGAL02603 (MSC12868)_2006-001910-33 | 
            Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to            Commission Guideline 2012/C 302/03
            for further information.    
 
				
